Supplementary Figure S2 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial
Puntos clave
MAIN FINDING: Spatial transcriptomics provides insights into osteosarcoma in canine patients enrolled in clinical trials.
KEY EVIDENCE: The study highlights the relationship between upper quartile counts and geometric means of negative control probes.
APPROACH: This analysis uses data from clinical trial participants, focusing on osteosarcoma-bearing dogs.
SIGNIFICANCE: Findings can enhance understanding of cancer biology and improve research methodologies using canine models.
Resumen
Supplementary Figure 2. The relationship between the upper quartile (Q3) of the counts in each segment with the geometric mean of the negative control probes.
Supplementary Figure S2 from Spatial Transcriptomics Advances the Use of Canine Patients in Cancer Research: Analysis of Osteosarcoma-Bearing Pet Dogs Enrolled in a Clinical Trial | Synapse